Dr Jillian Lau
Post-Doctoral Fellow, HIV Cure Clinical Research
Department of Infectious Diseases
55 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Knowledge and attitudes about solid organ transplantation for people with human immunodeficiency virus among Australian healthcare providers: a cross-sectional survey
DOI: 10.1111/imj.702872026
Journal article
From initial awareness to sustained involvement: using social and behavioral stage models to better understand engagement in HIV cure efforts in the Netherlands, France, Australia, and sub-saharan Africa
DOI: 10.1080/09540121.2025.25928892025
Journal article
Long-Term Outcomes Following Suppressive Antibiotic Therapy: A 10-Year Cohort Study
DOI: 10.3390/antibiotics141111642025
Journal article
The role of analytical treatment interruptions in shaping HIV-specific immunity and HIV cure
DOI: 10.1097/COH.00000000000009732025
Research contracts (non-grants)
The PEACH Study
2025
Research grants (ARC, NHMRC, MRFF)
Advancing Clinical Trials Towards a Cure for HIV
2022
Research contracts (non-grants)
Elite Controller Leuka Contract
RECENT SCHOLARLY WORKS
2025
Journal article
HIV and the gut: implications for HIV persistence, immune dysfunction and cure strategies
DOI: 10.3389/fimmu.2025.16508522024
Journal article
7.1 – 00113 Safety and PD-1 receptor occupancy with low dose Nivolumab in adults living with HIV on antiretroviral therapy: NIVO-LD
DOI: 10.1016/j.jve.2024.1004302024
Journal article
The Use of Long-term Antibiotics for Suppression of Bacterial Infections
DOI: 10.1093/cid/ciae3022024
Journal article
Reduction of HIV reservoir after stem cell transplantation
DOI: 10.1016/S2352-3018(24)00121-82024
Journal article
A Confusing Collapse: Case of an Intracranial Mass Mimicker in a Cardiac Transplant Recipient
DOI: 10.1093/cid/ciad6972024
Journal article
Assessing understandings and perceptions of HIV cure among peer navigators and treatment officers in Australia
DOI: 10.1080/25787489.2024.2330751
RECENT PROJECTS
2021
Research contracts (non-grants)
Safety, Immunogenicity and Efficacy of Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy (ART): NIVO-LD